Respiratory function at the end of the study (n=78)
| Variable | All patients | Men | Women |
|---|---|---|---|
| FEV1 (% predicted) | 70.5 (54–89) | 77.5 (62–95) | 60 (50.5–76.5)* |
| FEV1<30% predicted, n (%) | 2 (2.5) | 1 (2.2) | 1 (3.1) |
| 30%≤FEV1<50% predicted, n (%) | 12 (15.5) | 5 (10.9) | 7 (21.9) |
| 50%≤FEV1≤80% predicted, n (%) | 37 (46) | 18 (39.1) | 19 (59.4) |
| FEV1>80% predicted, n (%) | 27 (36) | 22 (47.8) | 5 (15.6) |
| FEV1 (L) | 2.3 (1.6–3.4) | 3.2 (2.3–3.8) | 1.6 (1.4–2.0)* |
| FVC (% predicted) | 87 (66–98) | 93 (72–101) | 76 (61–89)* |
| FVC (L) | 3.5 (2.3–4.7) | 4.5 (3.6–5.0) | 2.2 (1.8–2.9) * |
| TLC (% predicted) | 103 (93–114) | 103 (92–109) | 104 (95–117) |
| TLC (L) | 6.1 (5.1–7.1) | 6.9 (6.3–7.7) | 5.0 (4.4–5.4)* |
| FEV1/FVC | 0.71 (0.62–0.81) | 0.70 (0.62–0.80) | 0.72 (0.58–0.83) |
Results are shown as median (25–75).
*p<0.05 between men and women.
TLC, total lung capacity.